The natural compound GL22, isolated from Ganoderma mushrooms, suppresses tumor growth by altering lipid metabolism and triggering cell death

Autor: Shan Kuang, Chaomin Sun, Rui Liu, Ruobing Cao, Kai Wang, Ge Liu, Hongwei Liu, Li Bao
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Cancer Research
Programmed cell death
Cardiolipins
Cell Survival
Immunology
Mice
Nude

Antineoplastic Agents
Apoptosis
Fatty Acid-Binding Proteins
Models
Biological

Article
Metastasis
03 medical and health sciences
Cellular and Molecular Neuroscience
chemistry.chemical_compound
0302 clinical medicine
Adenosine Triphosphate
Oxygen Consumption
Cell Line
Tumor

medicine
Cardiolipin
Animals
lcsh:QH573-671
Cell Proliferation
Biological Products
Mice
Inbred BALB C

Chemistry
lcsh:Cytology
Biphenyl Compounds
Lipid metabolism
Ganoderma
Cell Biology
Metabolism
Lipid Droplets
medicine.disease
Lipid Metabolism
Triterpenes
Cell biology
Mitochondria
030104 developmental biology
Cell culture
030220 oncology & carcinogenesis
Cancer cell
Pyrazoles
lipids (amino acids
peptides
and proteins)

Reprogramming
Zdroj: Cell Death and Disease, Vol 9, Iss 6, Pp 1-14 (2018)
Cell Death & Disease
ISSN: 2041-4889
DOI: 10.1038/s41419-018-0731-6
Popis: Cancer cells rewire their metabolism to satisfy the demands of uncontrolled proliferation and survival. The reprogramming of lipid metabolism supports tumor growth, metastasis, and therapy-resistance. Therefore, targeting lipid metabolic reprogramming is a potential cancer treatment strategy. We recently isolated the novel natural triterpene GL22 from Ganoderma leucocontextum, a traditional Chinese medicine. Here, we show that GL22 significantly inhibits the growth of the liver cancer cell line Huh7.5 in vitro and of Huh7.5-derived tumor xenografts in vivo. We further find that GL22 induces mitochondrial dysfunction and cell death in Huh7.5 cells, in part due to fatty acid immobilization and loss of the mitochondrial lipid cardiolipin, which has vital structural and metabolic functions. Importantly, we demonstrate that GL22 treatment decreases the expression of fatty acid-binding proteins (FABPs), which likely underlies the loss of cardiolipin, mitochondrial dysfunction, and cell death. The over-expressions of FABPs prevented the GL22-induced cell death, loss of cardiolipin, decrease of ATP production, and reduction of oxygen consumption rate in Huh7.5 cells. Our results support targeting lipid metabolism via manipulating FABPs as a cancer treatment strategy, and promote Chinese medicine as an important source of novel anticancer drugs.
Databáze: OpenAIRE